‘‘

Our investing strategy over two decades has been built upon an ability to differentiate our capital in order to obtain advantaged price discovery. Thought fluency with a number of core industries, our brand, our relationships and our consistent focus on the middle market are all important ingredients to our track record.

 
 

Biography

Homer Sun is the Chief Investment Officer of Morgan Stanley Private Equity Asia (MSPEA), a Managing Director of Morgan Stanley and Co-Head of MSPEA’s China Investment Operations. Mr. Sun also serves on the Firm’s China Management Committee, which is comprised of the Firm’s senior business leaders within China. 

Mr. Sun has spent over 18 years at Morgan Stanley in Asia. Mr. Sun has led MSPEA’s private equity transactions in China for three funds to date: the $525 million Asia Fund II (2005), the $1.5 billion Asia Fund III (2007) and the current $1.7 billion Asia Fund IV. Mr. Sun’s board directorships have included: Sihuan Pharmaceutical, Renfang Medical, Noah Education, Shanshui Cement, Tianhe Chemicals, China XD Plastics and Nature Home. Prior to joining Morgan Stanley, Mr. Sun was a mergers and acquisitions lawyer with the law firm Simpson Thacher & Bartlett in New York and Hong Kong. Mr. Sun is Chinese and is based in Hong Kong.  

Mr. Sun received a B.S.E. in chemical engineering, magna cum laude, from the University of Michigan and a J.D., cum laude, from the University of Michigan Law School.
 
 
Homer is a member of the Morgan Stanley Private Equity Asia
 
 
 

May not represent all Team Members.

The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.

 

Morgan Stanley Investment Management (Australia) Pty Limited operates under AFSL No: 314182.

Not to be shown, quoted or distributed to the public. The information shown in this website is not personal advice and does not take into account the investment objectives, financial situation or needs of any person.

Information on this website should not be considered a solicitation to buy, an offer to sell or a recommendation for any security in any jurisdiction where such an offer, solicitation or recommendation would be unlawful or unauthorized. In addition, investments may not be made via this website.

Past performance of any product described on this site is not a reliable indication of future performance.


Privacy & Cookies    •    Terms of Use

©  Morgan Stanley | Investment Management (Australia) Pty Limited ACN 122040037